Your account is not claimed yet. You can sign up with ORCID to claim your account.

Khalid Shah

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 22

Top Venues

Science translational medicine

Cancer gene therapy

Stem cells (Dayton, Ohio)

Science advances

Brigham and Women's Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Brigham and Women's Hospital

United States

Vice Chair of Research; Director - CSTI :: Neurosurgery

Publications

Susana Moleirinho, Yohei Kitamura, Paulo S G N Borges, Sophia Auduong, Seyda Kilic, David Deng, Nobuhiko Kanaya, David Kozono, Jing Zhou, Jeffrey J Gray, Esther Revai-Lechtich, Yanni Zhu, Khalid Shah
Fate and Efficacy of Engineered Allogeneic Stem Cells Targeting Cell Death and Proliferation Pathways in Primary and Brain Metastatic Lung Cancer. Stem cells translational medicine (2023)
Kok-Siong Chen, Clemens Reinshagen, Thijs A Van Schaik, Filippo Rossignoli, Paulo Borges, Natalia Claire Mendonca, Reza Abdi, Brennan Simon, David A Reardon, Hiroaki Wakimoto, Khalid Shah
Bifunctional cancer cell-based vaccine concomitantly drives direct tumor killing and antitumor immunity. Science translational medicine 15 (677) (2023)
Kok-Siong Chen, Clemens Reinshagen, Thijs A Van Schaik, Filippo Rossignoli, Paulo Borges, Natalia Claire Mendonca, Reza Abdi, Brennan Simon, David A Reardon, Hiroaki Wakimoto, Khalid Shah
Bifunctional cancer cell-based vaccine concomitantly drives direct tumor killing and antitumor immunity. Science translational medicine 15 (677) (2023)
Kok-Siong Chen, Clemens Reinshagen, Thijs A Van Schaik, Filippo Rossignoli, Paulo Borges, Natalia Claire Mendonca, Reza Abdi, Brennan Simon, David A Reardon, Hiroaki Wakimoto, Khalid Shah
Bifunctional cancer cell-based vaccine concomitantly drives direct tumor killing and antitumor immunity. Science translational medicine 15 (677) (2023)
Darshini Kuruppu, Deepak Bhere, Christian T Farrar, Khalid Shah, Anna-Liisa Brownell, Umar Mahmood, Kenneth K Tanabe
Oncolytic HSV1 targets different growth phases of breast cancer leptomeningeal metastases. Cancer gene therapy (2023)
Darshini Kuruppu, Deepak Bhere, Christian T Farrar, Khalid Shah, Anna-Liisa Brownell, Umar Mahmood Umar Mahmood, Kenneth K Tanabe
Oncolytic HSV1 targets different growth phases of breast cancer leptomeningeal metastases. Cancer gene therapy (2023)
Darshini Kuruppu, Deepak Bhere, Christian T Farrar, Khalid Shah, Anna-Liisa Brownell, Umar Mahmood, Kenneth K Tanabe
Correction to: Oncolytic HSV1 targets different growth phases of breast cancer leptomeningeal metastases. Cancer gene therapy (2023)
Nobuhiko Kanaya, Yohei Kitamura, Maria Lopez Vazquez, Arnaldo Franco, Kok-Siong Chen, Thijs A Van Schaik, Touraj Aligholipour Farzani, Paulo Borges, Toru Ichinose, Waleed Seddiq, Shinji Kuroda, Genevieve Marie Boland, Nusrat Jahan, David E Fisher, Hiroaki Wakimoto, Khalid Shah
Gene-edited and -engineered stem cell platform drives immunotherapy for brain metastatic melanomas. Science translational medicine 15 (698) (2023)
Darshini Kuruppu, Deepak Bhere, Christian T Farrar, Khalid Shah, Anna-Liisa Brownell, Umar Mahmood Umar Mahmood, Kenneth K Tanabe
Oncolytic HSV1 targets different growth phases of breast cancer leptomeningeal metastases. Cancer gene therapy (2023)
Chuang Liu, Khalid Shah
Taming CAR T cell therapy toxicity. Nature materials (2023)
Kok-Siong Chen, Clemens Reinshagen, Thijs A Van Schaik, Filippo Rossignoli, Paulo Borges, Natalia Claire Mendonca, Reza Abdi, Brennan Simon, David A Reardon, Hiroaki Wakimoto, Khalid Shah
Bifunctional cancer cell-based vaccine concomitantly drives direct tumor killing and antitumor immunity. Science translational medicine 15 (677) (2023)
Filippo Rossignoli, Danielle Hoffman, Emaan Atif, Khalid Shah
Developing and characterizing a two-layered safety switch for cell therapies. Cancer biology & therapy 24 (1) (2023)
Deepak Bhere, Sung Hugh Choi, Pim van de Donk, David L Hope, Kiki Gortzak, Amina Kunnummal, Jasneet Khalsa, Esther Revai-Lechtich, Clemens Reinshagen, Victoria Leon, Nabil Nissar, Wenya Linda Bi, Cheng Feng, Hongbin Li, Yu Shrike Zhang, Steven H Liang, Neil Vasdev, Walid Ibn Essayed, Pablo Valdes Quevedo, Alexandra Golby, Naima Banouni, Anna Palagina, Reza Abdi, Brian Fury, Stelios Manolis Smirnakis, Alarice Lowe, Brock Reeve, Arthur Hiller, E Antonio Chiocca, Glenn Prestwich, Hiroaki Wakimoto, Gerhard Bauer, Khalid Shah
Target receptor identification and subsequent treatment of resected brain tumors with encapsulated and engineered allogeneic stem cells. Nature communications 13 (1) (2022)
Nihal Karakaş, Süleyman Üçüncüoğlu, Damla Uludağ, Birnur Sinem Karaoğlan, Khalid Shah, Gürkan Öztürk
Mesenchymal Stem Cell-Based COVID-19 Therapy: Bioengineering Perspectives. Cells 11 (3) (2022)
Na Song, Hiroaki Wakimoto, Filippo Rossignoli, Deepak Bhere, Rachele Ciccocioppo, Kok-Siong Chen, Jasneet Kaur Khalsa, Ilenia Mastrolia, Anna Valeria Samarelli, Massimo Dominici, Khalid Shah
Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm. Stem cells (Dayton, Ohio) 39 (6) (2021)
Yohei Kitamura, Nobuhiko Kanaya, Susana Moleirinho, Wanlu Du, Clemens Reinshagen, Nada Attia, Agnieszka Bronisz, Esther Revai Lechtich, Hikaru Sasaki, Joana Liliana Mora, Priscilla Kaliopi Brastianos, Jefferey L Falcone, Aldebaran M Hofer, Arnaldo Franco, Khalid Shah
Anti-EGFR VHH-armed death receptor ligand-engineered allogeneic stem cells have therapeutic efficacy in diverse brain metastatic breast cancers. Science advances 7 (10) (2021)
Nahid Arghiani, Khalid Shah
Modulating microRNAs in cancer: Next-generation therapies. Cancer biology & medicine (2021)
Ahmet Cingöz, Ezgi Ozyerli-Goknar, Tunc Morova, Fidan Seker-Polat, Myvizhi E Selvan, Zeynep Hülya Gümüş, Deepak Bhere, Khalid Shah, Ihsan Solaroglu, Tugba Bagcı-Önder
Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization. Oncogene 40 (18) (2021)
Jasneet Kaur Khalsa, Nina Cheng, Joshua Keegan, Ameen Chaudry, Joseph Driver, Wenya Linda Bi, James Lederer, Khalid Shah
Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types. Nature communications 11 (1) (2020)
Oren Levy, Rui Kuai, Erika M J Siren, Deepak Bhere, Yuka Milton, Nabeel Nissar, Michael De Biasio, Martina Heinelt, Brock Reeve, Reza Abdi, Meshael Alturki, Mohanad Fallatah, Abdulaziz Almalik, Ali H Alhasan, Khalid Shah, Jeffrey M Karp
Shattering barriers toward clinically meaningful MSC therapies. Science advances 6 (30) (2020)
Sanam L Kavari, Khalid Shah
Engineered stem cells targeting multiple cell surface receptors in tumors. Stem cells (Dayton, Ohio) 38 (1) (2019)
Deepak Bhere, Rajiv Kumar Khajuria, William T Hendriks, Antara Bandyopadhyay, Tugba Bagci-Onder, Khalid Shah
Stem Cells Engineered During Different Stages of Reprogramming Reveal Varying Therapeutic Efficacies. Stem cells (Dayton, Ohio) 36 (6) (2018)

Khalid Shah.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Khalid Shah